BSE filing, NSE: EBIX. Summary written from the filing by ALFA Finder's alert engine.
EBIX Ltd: key numbers
- Share price
- ₹13.90
- Market cap
- ₹297.9 Cr
- Revenue (annual)
- ₹2,438 Cr
- Net profit (annual)
- ₹-412.8 Cr
- P/E (TTM)
- -0.7×Sector 43.7×
- Promoter holding
- 42.70%+0.00% QoQ
- FII holding
- 15.06%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from EBIX Ltd
All →EBIX Management Change
EBIX Ltd appointed three new Independent Directors and noted cessation of three existing ones, effective October 6, 2026. The board reconstitution follows NCLT directions and NRC recommendations.
EBIX Annual General Meeting
Ebix Limited conducted its 60th Annual General Meeting on September 30, 2026. The proceedings covered the adoption of financial statements and a business performance overview.
EBIX Annual Report
Ebix Limited has filed its 60th Annual Report for the financial year 2025-26 with the stock exchange, fulfilling its regulatory compliance obligations.
EBIX Annual General Meeting
Ebix Limited has scheduled the closure of its register of members and share transfer books from September 24, 2026, to September 30, 2026, for its AGM.
EBIX Board Meeting Outcome
Ebix Limited announced the schedule for its 60th Annual General Meeting, set for September 30, 2026. The Board also approved related annual reports and audit documents.
EBIX Business Update
Ebix Limited employees launched a donation drive with Saahas NGO for Assam flood relief. Nearly 4,000 employees contributed over 350 boxes of essential relief materials.
Other other announcement announcements
All →eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.